Development of a novel heart failure risk tool: the barcelona bio-heart failure risk calculator (BCN bio-HF calculator).
<h4>Background</h4>A combination of clinical and routine laboratory data with biomarkers reflecting different pathophysiological pathways may help to refine risk stratification in heart failure (HF). A novel calculator (BCN Bio-HF calculator) incorporating N-terminal pro B-type natriuret...
Guardado en:
Autores principales: | Josep Lupón, Marta de Antonio, Joan Vila, Judith Peñafiel, Amparo Galán, Elisabet Zamora, Agustín Urrutia, Antoni Bayes-Genis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/344d0afbc1ac4055961157215ff7fc75 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Limited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratification.
por: Elisabet Zamora, et al.
Publicado: (2012) -
Heart Failure Treatment by Device
por: Antoni Bayés-Genis
Publicado: (2020) -
The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizations
por: Julio Núñez, et al.
Publicado: (2021) -
Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018
por: Giosafat Spitaleri, et al.
Publicado: (2021) -
Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence
por: Antoni Bayes-Genis, et al.
Publicado: (2021)